Abstract:Abstract Background Lung cancer in very young adults in China aged <30 is on the rise and the clinicopathological characteristics of this unique population are incomplete and are yet to be elucidated. Our study aims to explore the characteristics, trends and distinctive features of lung cancer this age group to provide more information that can aid in developing optimal treatment regimens and improve prognosis for this exclusive age group. Method A retrospective review of 141 lung cancer patients admitted at our hospital from August 2011 to October 2021 was performed. The focused age group in our study was 18-30 years old. The data collected included demographics, tumor pathology, gene mutations, and treatment. Overall survival and prognosis were systematically analyzed. Results From a total of 141 of young lung cancer patients, 139 were included in final analysis. The gender distribution in our series favored female(65.5%), and only 7.2% of the study cohort had a history of smoking. Adenocarcinoma was the most common histological type in our study, presenting 93.5% of all patients. The most common stages at diagnosis was stage I(61.2%) and stage IV(30.2%). Genetic testing was performed in only 24.5% (34/139) of the patients. From the 23/34 patients in our study who tested positive for a genetic mutation, 19 (82.3%) were stage IV. The most common gene mutation was Anaplastic Lymphoma kinase(ALK) rearrangement observed in 13/23 (56.5%) gene mutation positive patients. Among stage IV NSCLC, OS was longer in patients who received targeted therapy, compared to the patients not receiving target therapy: 88 months vs 24 months (95% CI: 0.15-1.0, p=0.0282). Conclusion Lung cancer in the young adult population has particular characteristics (Common in female, non-smoker and adenocarcinoma patients). Higher stages of disease were observed in those with a gene mutation (notably ALK rearrangement). Although the sample size was small, the current data suggests a higher mutation rate in the younger population. These findings have fundamental implications for practice and we propose that all patients under 30 diagnosed with lung cancer should undergo genetic testing so they can receive personalized treatment and therefore achieve better outcomes.

Pulmonary carcinoma in aged patients over 70 years old. An analysis of 100 cases

Comparison between young and old patients with lung cancer

A Clinical Analysis of Lung Cancer in Elderly Patients

Surgical Treatment of Lung Carcinoma in the Elder

Diagnosis Status and Pathological Diagnosis Derived Treatment of Elderly Lung Cancer Patients over 75 Years Old

Analysis of Survival Data in Patients with Advanced Non-Small-Cell Lung Cancer Aged 60 Years and Over

Complications and outcomes after pulmonary resection for cancer in patients 80 to 89 years of age

Prognostic Factors in Older Patients with Advanced Non-Small Cell Lung Cancer in China.

Demographics, Risk Factors and Survival Analysis of Lung Cancer in Young Adults (&lt;30 Years) in China-A Retrospective Cohort Study

[A Retrospective Analysis: Comparison of the Clinical Characteristics and Prognosis in Elderly and Young Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer.].

Changing Trends in Gastric and Colorectal Cancer among Surgical Patients over 85 Years Old: A Multicenter Retrospective Study, 2001–2021

Survival and Outcomes of Surgical Treatment of the Elderly NSCLC in China: a Retrospective Matched Cohort Study.

Clinicopathological characteristics and prognostic factors of pulmonary sarcomatoid carcinoma: a large population analysis

Clinical Features and Gene Mutations of Lung Cancer Patients 30 Years of Age or Younger

Clinicopathological Features and Treatment Sensitivity of Elderly Chinese Breast Cancer Patients.

Metastasis Patterns and Prognosis of Octogenarians with NSCLC: A Population-based Study.

Primary Lung Seminoma in a 76-Year-old Man: a Case Report.

The featore and the prognosis analyising of the elderly advanced lung cancer

Clinicopathological Features, Treatment and Prognosis of Invasive Breast Cancer Patients over 70 Years Old

Investigating the Genomic Alteration Improved the Clinical Outcome of Aged Patients with Lung Carcinoma

Efficacy and safety of PD‐1/PD‐L1 inhibitors in elderly patients with advanced non‐small cell lung cancer